JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 7, 2006; DOI: 10.1124/jpet.106.101261


0022-3565/06/3181-90-98$20.00
JPET 318:90-98, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.101261v1
318/1/90    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu-Wong, J. R.
Right arrow Articles by Reinhart, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu-Wong, J. R.
Right arrow Articles by Reinhart, G. A.

CARDIOVASCULAR

Role of Phosphorus and Vitamin D Analogs in the Pathogenesis of Vascular Calcification

J. Ruth Wu-Wong, William Noonan, Junli Ma, Doug Dixon, Masaki Nakane, Antoinette L. Bolin, Kristin A. Koch, Steve Postl, Sherry J. Morgan, and Glenn A. Reinhart

Abbott Laboratories, Abbott Park, Illinois

Vascular calcification is a mortality risk factor for stage 5 chronic kidney disease patients. We investigated the role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification using in vivo, ex vivo, and in vitro models. Our results demonstrate that uremic rats receiving a hyperphosphatemia-inducing diet did not exhibit aortic calcification despite elevated levels of serum phosphorus and calcium-phosphorus (CaxP) product. The vitamin D analog 1{alpha}-hydroxyvitamin-D2 [1{alpha}(OH)D2] at 0.17 µg/kg raised serum calcium, phosphorus, CaxP product, and aortic calcification in the uremic rats, but 19-nor-1{alpha},25(OH)2D2 (19-nor) at the same dose had no significant effect. At 0.67 µg/kg, both 1{alpha}(OH)D2 and 19-nor had similar effects on serum calcium, phosphorus, and CaxP product, but only 1{alpha}(OH)D2 induced significant aortic calcification. Only aortic rings from 1{alpha}(OH)D2-treated uremic rats exhibited a significant increase in 45Ca uptake ex vivo. When aortic rings from normal rats or a primary culture of human coronary artery smooth muscle cells were treated with phosphorus or vitamin D analogs in vitro, high phosphorus induced calcium accumulation and/or 45Ca uptake in a dose- or time-dependent manner, whereas vitamin D analogs including 1{alpha}(OH)D2 up to 100 nM had no significant effect despite the presence of a functional vitamin D receptor. However, serum from 1{alpha}(OH)D2-treated uremic rats induced 45Ca uptake into smooth muscle cells cultured in high phosphorus. These results suggest that the regulation of vascular calcification in vivo cannot be easily replicated in the ex vivo or in vitro models, and high phosphorus and some vitamin D analogs such as 1{alpha}(OH)D2 exert interactive effects on modulating vascular calcification.


Received for publication January 11, 2006
Accepted April 6, 2006.

Address correspondence to: Dr. J. Ruth Wu-Wong, Abbott Laboratories, R4CM, AP52, 200 Abbott Park Rd., Abbott Park, IL 60064. E-mail: ruth.r.wuwong{at}abbott.com




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
M. Mizobuchi, D. Towler, and E. Slatopolsky
Vascular Calcification: The Killer of Patients with Chronic Kidney Disease
J. Am. Soc. Nephrol., July 1, 2009; 20(7): 1453 - 1464.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. J. Matias, C. Ferreira, C. Jorge, M. Borges, I. Aires, T. Amaral, C. Gil, J. Cortez, and A. Ferreira
25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients
Nephrol. Dial. Transplant., February 1, 2009; 24(2): 611 - 618.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. Noonan, K. Koch, M. Nakane, J. Ma, D. Dixon, A. Bolin, and G. Reinhart
Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3824 - 3830.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Mathew, R. J. Lund, L. R. Chaudhary, T. Geurs, and K. A. Hruska
Vitamin D Receptor Activators Can Protect against Vascular Calcification
J. Am. Soc. Nephrol., August 1, 2008; 19(8): 1509 - 1519.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. C. Palmer, D. O. McGregor, P. Macaskill, J. C. Craig, G. J. Elder, and G. F.M. Strippoli
Meta-analysis: Vitamin D Compounds in Chronic Kidney Disease
Ann Intern Med, December 18, 2007; 147(12): 840 - 853.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. R. Wu-Wong, M. Nakane, J. Ma, X. Ruan, and P. E. Kroeger
Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1592 - F1604.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.